Physician profile
John Kelly
NPI 1336696780
$17,914.39
in general payments reported to CMS, 2019-2025
20 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Occupational Health (Nurse Practitioner) provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,026 · 2022: $4,124 · 2023: $4,253 · 2024: $4,312 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,400 · Food and Beverage: $2,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,400.00 |
| Food and Beverage | $2,364.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $13,306.67 | 2021-2024 | Venacure 1470 Pro |
| Amgen INC. | $2,945.69 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $405.04 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $223.08 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.21 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.97 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $151.93 | 2021-2024 | Amvuttra |
| Treace Medical Concepts, INC. | $129.46 | 2025 | |
| Lilly USA, LLC | $64.22 | 2021-2024 | Mounjaro |
| Pfizer INC. | $53.49 | 2021-2023 | |
| Baxter Healthcare | $43.64 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $35.59 | 2022 | |
| Smith+Nephew, INC. | $31.50 | 2025 | Collagenase Santyl |
| Bardy Diagnostics, INC. | $30.00 | 2022 | |
| Abiomed | $23.62 | 2024 | Impella |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.64 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $19.20 | 2024 | Opsumit, Uptravi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.00 | 2025 | Jublia |
| Lexicon Pharmaceuticals, INC. | $14.57 | 2023 | Inpefa |
| Tactile Systems Technology INC | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.